CSI Market
Sign In | Register

Agilon Health Inc (AGL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AGL Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Agilon Health Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income66.87
Depreciation & amortization13.65
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total19.00
Share-based Compensation30.09
Income (Loss) from Equity Method Investments4.14
Gains (Losses) on Extinguishment of Debt0.00
Distributions Of Earnings From Equity Method Investments-
Deferred Income Taxes And Uncertain Tax Positions-
Increase Decrease In Medical Claims And Related Payables-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital122.42
Other Noncash Income (Expense)-1.38
Other net0.00
Payments for (Proceeds from) Other Operating Activities-307.36
Discontinued operations19.00
Net Cash flow from Operating Activities-33.57
Investing Activities
Capital Expenditures-7.43
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities46.62
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Net Cash Paid In Business Combination-
Payments To Acquire Loans Receivable And Other-1.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Proceeds from Collection of Loans Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities39.18
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-1.61
Long-term debt - borrowings0.00
Long-term debt - repayments-3.50
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment Of Equity And Debt Issuance Costs And Other-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.52
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-41.00
Total Cash Flow5.10
4 historic quarters locked

Sign in to unlock the full Agilon Health Inc cash flow history.

Sign In Create Free Account

About Agilon Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: agl-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-053355

Figures are derived from filed reports and may be restated. Historical data is subject to revision.